drugset / Trial / NCT00282139

Aripiprazole in the Treatment of Tourette's Syndrome

NCT00282139

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is an open-label, flexible dose study designed to evaluate the safety and efficacy of aripiprazole in TS (or chronic tic disorder) subjects with or without associated OC symptoms and with or without ADHD symptoms.

Timeline

Start
2004-01
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified

Indications